Canada markets open in 1 hour

Noble Midstream Partners LP (NBLX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
15.17+0.02 (+0.13%)
At close: 4:00PM EDT

15.19 +0.02 (0.13%)
Pre-Market: 7:50AM EDT

Full screen
Trade prices are not sourced from all markets
Previous Close15.15
Bid0.00 x 800
Ask15.38 x 4000
Day's Range14.95 - 15.19
52 Week Range5.62 - 15.63
Avg. Volume824,832
Market Cap1.371B
Beta (5Y Monthly)3.36
PE Ratio (TTM)8.82
EPS (TTM)1.72
Earnings DateMay 07, 2021 - May 10, 2021
Forward Dividend & Yield0.75 (4.95%)
Ex-Dividend DateFeb. 04, 2021
1y Target Est13.63
  • Business Wire

    Noble Midstream Announces Update on Anticipated Timing of Merger Closing and Quarterly Distribution

    Noble Midstream Partners LP (NASDAQ: NBLX) ("Noble Midstream" or the "Partnership") announced today that it expects to close the previously announced merger transaction with Chevron Corporation ("Chevron") in mid-May. Under the terms of the merger agreement, at the closing, all of the publicly held common units representing limited partner interests in the Partnership will convert into the right to receive newly issued shares of Chevron common stock. As a result, Partnership unitholders are not expected to receive a quarterly distribution from the Partnership for the quarter ended March 31, 2021, and instead, unitholders are expected to receive a quarterly dividend, payable June 10, 2021, from Chevron for the quarter ended March 31, 2021, provided that such unitholders continue to hold the shares of Chevron common stock received in the merger on May 19, 2021, the record date for the Chevron quarterly dividend.

  • Chevron (CVX) Decides to Stall Funding of Kitimat LNG Project

    Chevron (CVX) Decides to Stall Funding of Kitimat LNG Project

    Chevron (CVX) has Woodside Energy Limited of Australia as the 50-50 joint-venture partner in the Kitimat LNG project.


    Lifshitz Law Firm, P.C. Announces Investigation of FPRX, NBLX, PAND, and SHBI

    NEW YORK, NY / ACCESSWIRE / March 21, 2021 / Five Prime Therapeutics, Inc. (NASDAQ:FPRX) Lifshitz Law Firm, P.